In the autoimmune disease systemic lupus erythematosus (SLE), 1 antibodies reactive with nuclear and cell surface components are a general finding (I, 2). By contrast, in myositis, an inflammatory disease of muscle, autoantibodies are often directed at cytoplasmic components (3). The most common target, Jo-1, was recently identified as the enzyme, histidyl-tRNA synthetase (4). Antibodies to Jo-1 are found in 25-30% of myositis patients (5-7), particularly in patients with myositis and interstitial lung disease, where the frequency is ~70% (6, 7). In this paper we identify a second, less common autoantibody found chiefly, though not exclusively, in myositis. We show that it is directed at another charging enzyme, threonyl-tRNA synthetase, and that the antigenic site recognized by the human autoantibody differs from that recognized by an experimental antibody raised in rabbits. We discuss the association between myositis and autoantibodies to tRNA-related antigens.
Patients and MethodsPatients. Five examples of the PL-7 precipitin system were studied: Three were obtained in a survey of 84 patients with myositis, the fourth from a study of 10 myositis sera giving cytoplasmic immunofluorescence on the HEp-2 cell line, and the fifth by screening sera from >1,000 patients with other forms of systemic autoimmune disease (8), using counterimmunoelectrophoresis (CIE) (9).tmmunofluorescence. Indirect immunofluorescence was performed with HEp-2 cells as substrate using fluorescein-labeled anti-human immunoglobulin provided by the supplier (Immunoconcepts, Inc., Sacramento, CA). Serum was diluted 1:40 in phosphate-buffered saline (PBS). Slides were read on a Nikon Optiphot ultraviolet microscope equipped with filters for fluorescein.Preparation oflgG. All experiments used lgG isolated from serum by chromatography on DEAE-Sephadex A-50 columns run in 0.01 M Na phosphate at pH 7.2. Fractions with absorbance >0.8 at 280 nm were pooled, restored to 150 mM NaCI by the addition of salt, and held at -20°C. As used, IgG stocks were generally 0.7-1 mg/ml.Cell Labeling. For [35S]methionine labeling, subconfluent HeLa cell monolayers were incubated for 5 h with [3'~S]methionine (New England Nuclear, Boston, MA) at 0.5 mCi/ This work was supported by grants to M. Mathews from the Muscular Dystrophy Association, to M.